All practice questions

4736 questions

Question 3481Question →

A 65-year-old man is evaluated in the hospital on postoperative day 7 following a right total knee arthroplasty. He has been receiving prophylactic subcutaneous enoxaparin since surgery. Today, a routine complete blood count shows a platelet count of 95,000/μL, representing a significant drop from his preoperative baseline of 280,000/μL. The patient also complains of new-onset right calf pain and swelling. Physical examination reveals unilateral right lower extremity edema, erythema, and tenderness to palpation.

Arrange the following urgent diagnostic and therapeutic interventions in the most appropriate chronological sequence for managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of interventions is: 1) Discontinue enoxaparin, 2) Draw blood for PF4-heparin antibodies, 3) Initiate a direct thrombin inhibitor (argatroban), 4) Perform venous duplex ultrasonography, and 5) Initiate warfarin only after platelet recovery.
The correct chronological sequence prioritizes halting the pathophysiologic trigger (stopping heparin) and immediately preventing catastrophic clot propagation (starting a direct thrombin inhibitor). Drawing diagnostic labs must precede the new drug to avoid confounding, while imaging is safely done once systemic anticoagulation is running. Finally, warfarin is strictly delayed until the acute consumptive phase resolves (platelets >150,000/μL) to prevent Protein C-depletion-induced venous limb gangrene.

Step-by-Step Solution

1
Calculate the 4T's score to determine the clinical probability of heparin-induced thrombocytopenia.
High clinical probability is established.
The patient has a >50% drop in platelets (2 points), appropriate timing of 7 days (2 points), and new suspected thrombosis (2 points), necessitating immediate action.
2
Discontinue all heparin products and draw diagnostic baseline labs.
Immune-mediated platelet activation is halted and pristine lab samples are secured.
Continuing heparin worsens the prothrombotic state. Labs must be drawn before confounding treatments are administered.
3
Initiate an alternative, non-heparin systemic anticoagulant (e.g., argatroban).
The patient is protected from further catastrophic clot propagation.
HIT is extremely prothrombotic. Systemic anticoagulation is required immediately, prior to radiographic confirmation of the local clot.
4
Obtain objective imaging (venous duplex ultrasonography) of the lower extremities.
The exact location and extent of the deep vein thrombosis are mapped.
Imaging guides localized management and establishes a baseline for future comparison once the patient is systemically safe.
5
Delay warfarin initiation until the platelet count normalizes (>150,000/μL).
Safe transition to long-term oral anticoagulation is achieved.
Early warfarin use causes severe Protein C depletion, which can trigger paradoxical venous limb gangrene in HIT patients.

Key Concept

The management of suspected Heparin-Induced Thrombocytopenia (HIT) with thrombosis requires immediate cessation of all heparin products, establishing diagnostic baseline labs, initiating an alternative non-heparin anticoagulant empirically, confirming the thrombosis via imaging, and strictly delaying warfarin initiation until platelet recovery to prevent venous gangrene.
Estimated Time:1m 30s
Question 3482Question →

A 74-year-old woman with unmedicated persistent atrial fibrillation is admitted with sudden-onset excruciating pain in her right lower extremity. Clinical evaluation reveals a cold, pale, and pulseless leg, highly suspicious for an acute thromboembolic occlusion of the superficial femoral artery. Place the following subcellular events in the correct chronological sequence as they occur within the ischemic skeletal myocytes during the resulting hypoxic injury.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the immediate loss of oxidative phosphorylation, followed by the failure of ATP-dependent pumps, cellular swelling, massive calcium influx, and finally, irreversible enzymatic membrane degradation.
Ischemic cell injury follows a highly predictable chronological cascade. First, the lack of oxygen halts mitochondrial oxidative phosphorylation, rapidly depleting ATP stores. This lack of ATP causes failure of the plasma membrane Na+/K+Na^+/K^+-ATPase, leading to intracellular sodium accumulation. The resulting osmotic gradient draws water into the cell, causing reversible cellular and organelle swelling. As ischemia persists, severe energy failure and early membrane stress result in a massive influx of cytosolic calcium. This high calcium concentration activates intracellular degradative enzymes (phospholipases, proteases, endonucleases) that destroy the cell membrane and cytoskeleton, marking the point of irreversible cellular necrosis.

Step-by-Step Solution

1
Identify the primary insult.
The acute arterial occlusion causes severe hypoxia (ischemia), which directly impairs oxygen-dependent mitochondrial processes.
Oxidative phosphorylation requires oxygen as the final electron acceptor.
2
Determine the immediate consequence of halted oxidative phosphorylation.
Failure of the Na+/K+Na^+/K^+-ATPase pump.
Ion pumps are highly ATP-dependent and are the first cellular mechanisms to fail when ATP stores are depleted.
3
Trace the osmotic consequence of ion pump failure.
Isosmotic influx of water and cellular swelling occur.
Trapped intracellular sodium creates an osmotic gradient that pulls water into the cell, representing the hallmark of early, reversible cell injury.
4
Identify the transition mechanism toward irreversible injury.
Massive cytosolic calcium accumulation takes place.
As ATP depletion becomes critical and prolonged, Ca2+Ca^{2+}-ATPase fails, and structural damage to the endoplasmic/sarcoplasmic reticulum releases sequestered calcium.
5
Establish the final irreversible mechanism.
Activation of phospholipases and irreversible membrane damage.
High intracellular calcium acts as a potent enzyme activator, turning on phospholipases, endonucleases, and proteases that destroy structural cellular components, finalizing the transition to necrosis.

Key Concept

Chronological sequence of subcellular events in ischemic cellular injury, progressing from reversible ATP depletion to irreversible membrane damage.
Estimated Time:1m 30s
Question 3483Question →

A pharmacology research team is investigating 'Compound Y' as a potential therapeutic agent for chronic heart failure. They perform a series of *in vitro* experiments using isolated cardiac myocytes that express wild-type β1\beta_1-adrenergic receptors. The team measures intracellular cyclic AMP (cAMP) production as the downstream pharmacodynamic response.

In the first experiment, they plot a dose-response curve for dobutamine, a full β1\beta_1 agonist. They then add a fixed, moderate concentration of Compound Y and repeat the dobutamine dose-response curve. The new curve demonstrates an unchanged maximum cAMP production (EmaxE_{max}) but a significantly increased EC50EC_{50} for dobutamine.

In the second experiment, the myocytes are exposed to increasing concentrations of Compound Y alone. The researchers observe a dose-dependent increase in cAMP production, but the maximal response plateaus at exactly 40%40\% of the EmaxE_{max} achieved by dobutamine.

In the third experiment, a maximal, saturating concentration of dobutamine is applied, producing a 100%100\% cAMP response. Increasing concentrations of Compound Y are then progressively added to this preparation.

Based on the receptor binding properties demonstrated in these experiments, what is the most likely outcome observed in the third experiment?

Show answer & explanation

Answer: The intracellular cAMP production will gradually decrease and plateau at 40%40\% of the maximal dobutamine response.

Answer

The intracellular cAMP production will gradually decrease and plateau at 40%40\% of the maximal dobutamine response.
The correct answer correctly identifies Compound Y as a partial agonist. Experiment 1 (rightward shift of the full agonist curve with unchanged EmaxE_{max}) demonstrates that Compound Y binds competitively to the same orthosteric site as dobutamine. Experiment 2 establishes that Compound Y possesses an intrinsic activity of 40%40\% compared to a full agonist. When a partial agonist is added to a system fully saturated by a full agonist (Experiment 3), it competes for receptor binding sites. As its concentration increases, it will eventually occupy all available receptors, displacing the full agonist. Because it possesses 40%40\% intrinsic activity, the receptor response will not drop to zero but will plateau at the partial agonist's maximum efficacy (40%40\%). In this setting, the partial agonist acts as a competitive antagonist, reducing the maximal response.

Step-by-Step Solution

1
Analyze the results of the first experiment to determine the type of receptor binding.
The unchanged EmaxE_{max} and increased EC50EC_{50} indicate that Compound Y is a competitive ligand binding to the same orthosteric site as the full agonist.
Competitive ligands can be overcome by increasing the concentration of the full agonist, thereby preserving the maximal response while requiring a higher dose to achieve it.
2
Analyze the results of the second experiment to determine the intrinsic activity (efficacy) of Compound Y.
Compound Y independently produces a response that plateaus at 40%40\% of the maximum possible response.
This demonstrates that Compound Y is a partial agonist possessing an intrinsic efficacy of 40%40\%.
3
Predict the outcome of the third experiment where a partial agonist is added to a system saturated by a full agonist.
As the concentration of the partial agonist increases, it competitively displaces the full agonist from the receptors. The overall response drops from 100%100\% and plateaus at 40%40\%.
At saturating concentrations, the partial agonist will occupy all available receptors. Therefore, the response will equal the maximal intrinsic activity of the partial agonist (40%40\%), effectively acting as a functional antagonist.

Key Concept

Pharmacodynamics of Partial Agonists
Question 3484Question →

A 19-year-old collegiate athlete is evaluated in the clinic for pre-participation sports clearance. He is entirely asymptomatic and reports excellent exercise tolerance during rigorous training. His family history is highly notable for the sudden, unexplained death of his older brother at age 22 during a basketball game. The patient's temperature is 37.0°C (98.6°F), blood pressure is 112/68 mm Hg, and pulse is 62/min. Cardiac auscultation reveals a regular rate and rhythm with a grade 3/6 harsh, crescendo-decrescendo systolic murmur heard best at the left lower sternal border. The murmur does not radiate to the carotid arteries.

Which of the following dynamic physical examination maneuvers would most likely result in an INCREASE in the intensity of this patient's murmur?

Show answer & explanation

Answer: Transitioning from a supine to a standing position

Answer

Transitioning from a supine to a standing position
The patient's clinical presentation—a harsh systolic murmur at the lower left sternal border and a family history of sudden cardiac death—strongly suggests hypertrophic cardiomyopathy (HCM). The murmur of HCM is caused by dynamic left ventricular outflow tract (LVOT) obstruction. Maneuvers that decrease left ventricular volume (by decreasing preload or afterload) exacerbate this obstruction and increase the murmur's intensity. Transitioning from a supine to a standing position causes venous pooling in the lower extremities, thereby decreasing venous return (preload). The reduced left ventricular end-diastolic volume brings the anterior leaflet of the mitral valve closer to the hypertrophied interventricular septum, worsening the LVOT obstruction and making the murmur louder.

Step-by-Step Solution

1
Identify the most likely diagnosis based on the clinical vignette.
The patient has hypertrophic cardiomyopathy (HCM), indicated by a harsh systolic murmur at the lower left sternal border and a family history of sudden cardiac death in a young relative.
A precise anatomical diagnosis is required to predict the physiological response to dynamic maneuvers.
2
Determine the pathophysiology of the murmur in the identified condition.
The murmur in HCM results from dynamic left ventricular outflow tract (LVOT) obstruction. The obstruction worsens when the left ventricular cavity volume is reduced.
Understanding the structural mechanism is key to evaluating how changes in hemodynamics affect the intensity of the murmur.
3
Evaluate the physiological effect of the maneuvers listed in the options.
Standing decreases venous return (preload), leading to a smaller left ventricular cavity. This exacerbates the LVOT obstruction, making the murmur louder.
Connecting the maneuver's hemodynamic effect to the underlying pathophysiology identifies which specific action will increase the murmur's intensity.

Key Concept

Dynamic auscultation and physiological maneuvers in the evaluation of hypertrophic cardiomyopathy.
Question 3485Question →

A 29-year-old woman, G1P1, is evaluated in the intensive care unit on postpartum day 4 for worsening fatigue, confusion, and significantly decreased urine output. She had an uncomplicated spontaneous vaginal delivery at term.

Temperature is 37.6°C (99.7°F), blood pressure is 168/102 mm Hg, heart rate is 108/min, and respiratory rate is 18/min. Physical examination reveals scleral icterus and scattered petechiae over her lower extremities.

Laboratory studies show:

TestResultReference Range
Hemoglobin7.1 g/dL12.0-16.0 g/dL
Platelet count32,000/mm³150,000-400,000/mm³
Leukocyte count9,400/mm³4,500-11,000/mm³
Creatinine3.9 mg/dL0.6-1.1 mg/dL
Aspartate aminotransferase (AST)22 U/L10-40 U/L
Alanine aminotransferase (ALT)28 U/L7-56 U/L
Lactate dehydrogenase (LDH)1,450 U/L140-280 U/L
Haptoglobin< 10 mg/dL41-165 mg/dL
Prothrombin time (PT)12 sec11-15 sec
Partial thromboplastin time (PTT)28 sec25-40 sec
ADAMTS13 activity68%> 60%
Direct antiglobulin (Coombs)NegativeNegative

Peripheral blood smear shows numerous schistocytes.

Which of the following best describes the precise mechanism of the most appropriate targeted pharmacotherapy for this patient's underlying condition?

Show answer & explanation

Answer: Binding to complement component C5 to prevent its cleavage and subsequent formation of the terminal membrane attack complex

Answer

The correct targeted pharmacotherapy is eculizumab, which functions by binding to complement component C5 to prevent its cleavage and the subsequent formation of the terminal membrane attack complex.
The patient's presentation of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury in the postpartum setting, combined with normal ADAMTS13 activity, normal coagulation studies, and normal liver enzymes, confirms a diagnosis of atypical hemolytic uremic syndrome (aHUS). aHUS is caused by dysregulation of the alternative complement pathway. The standard targeted pharmacotherapy is eculizumab (or ravulizumab), a monoclonal antibody that binds directly to complement protein C5. This binding prevents the cleavage of C5 into C5a (a potent anaphylatoxin) and C5b, thereby halting the formation of the C5b-9 terminal membrane attack complex (MAC) that causes the hallmark endothelial damage in this disease.

Step-by-Step Solution

1
Analyze the clinical presentation and primary laboratory findings to identify the overarching syndrome.
The patient has microangiopathic hemolytic anemia (schistocytes, high LDH, low haptoglobin), severe thrombocytopenia, and acute kidney injury.
This triad of findings definitively establishes a diagnosis of a thrombotic microangiopathy (TMA).
2
Differentiate the specific cause of the TMA by analyzing the exclusionary laboratory results.
Normal PT/PTT rules out DIC. Normal AST/ALT rules out HELLP syndrome. Normal ADAMTS13 activity rules out TTP.
Systematic exclusion of other TMAs leaves atypical hemolytic uremic syndrome (aHUS) as the definitive diagnosis, a condition frequently triggered by the postpartum state.
3
Identify the underlying immunopathologic mechanism of aHUS and its corresponding targeted therapy.
aHUS is driven by uncontrolled activation of the alternative complement pathway leading to endothelial damage. The standard targeted therapy is a C5 inhibitor (eculizumab).
Blocking C5 prevents its cleavage into C5a and C5b, terminating the cascade prior to the formation of the C5b-9 membrane attack complex, thus halting microvascular endothelial injury.

Key Concept

Diagnosis of atypical hemolytic uremic syndrome (aHUS) via exclusion of other TMAs, and management with C5 inhibitors (eculizumab) to block the terminal complement cascade.
Question 3486Question →

A 42-year-old woman is evaluated in the hospital on post-operative day 2 following a total thyroidectomy for papillary thyroid carcinoma. She reports new-onset tingling around her mouth and in her fingertips. Her temperature is 37.1°C (98.8°F), blood pressure is 118/76 mmHg, pulse is 82/min, and respirations are 14/min. The physician suspects a specific electrolyte abnormality related to her recent surgery. Which of the following physical examination maneuvers is most appropriate to demonstrate the expected physical finding for this condition?

Show answer & explanation

Answer: Inflation of a blood pressure cuff above systolic pressure for 3 minutes

Answer

Inflation of a blood pressure cuff above systolic pressure for 3 minutes
The patient's recent total thyroidectomy puts her at high risk for inadvertent parathyroid gland damage or removal, which leads to acute hypocalcemia. Perioral tingling and acral paresthesias are classic early symptoms of the resulting neuromuscular irritability. This can be confirmed on physical examination by eliciting Trousseau sign. This maneuver involves inflating a sphygmomanometer cuff above the patient's systolic blood pressure for 3 minutes, which restricts blood flow and exacerbates the irritability, resulting in a visible carpopedal spasm (flexion of the wrist and metacarpophalangeal joints, extension of the interphalangeal joints, and adduction of the thumb).

Step-by-Step Solution

1
Analyze the clinical scenario and the patient's surgical history.
The patient had a total thyroidectomy and is experiencing perioral and acral tingling.
Recognizing the risk of inadvertent parathyroid gland damage or removal during total thyroidectomy is essential for anticipating post-operative complications.
2
Identify the underlying pathophysiological derangement.
The symptoms represent increased neuromuscular irritability due to acute hypocalcemia.
Perioral numbness and fingertip paresthesias are classic early manifestations of lowered serum calcium.
3
Determine the appropriate physical examination maneuver to confirm the suspicion.
Trousseau sign should be elicited by inflating a blood pressure cuff above systolic pressure.
This maneuver induces carpopedal spasm, confirming the presence of significant neuromuscular irritability characteristic of hypocalcemia.

Key Concept

Physical Examination Findings in Post-thyroidectomy Hypocalcemia
Question 3487Question →

A 78-year-old woman is evaluated in the hospital for severe, watery diarrhea, abdominal cramping, and fever. She was admitted 5 days ago for a community-acquired pneumonia treated with ceftriaxone and azithromycin. Temperature is 38.6°C (101.5°F), blood pressure is 90/60 mm Hg, and pulse is 112/min. Physical examination reveals a distended, diffusely tender abdomen with guarding. Laboratory studies show a leukocyte count of 28,000/mm³ and a serum creatinine of 1.9 mg/dL. Flexible sigmoidoscopy reveals raised, yellowish-white plaques adherent to the colonic mucosa. Stool testing is positive for a highly virulent organism's exotoxins. The patient's condition is primarily driven by bipartite large clostridial toxins. Arrange the following cellular events in the correct chronological pathophysiological sequence mediating this toxin's intracellular effect.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Binding of the toxin -> Internalization and endosomal insertion -> IP6-induced autoproteolytic cleavage -> Glycosylation of Rho family GTPases -> Disruption of the actin cytoskeleton.
The pathophysiology of Clostridioides difficile Toxins A and B follows a highly orchestrated multi-step intracellular delivery cascade. The C-terminal domain of the toxin first binds to specific host cell receptors. The complex is then internalized into early endosomes via receptor-mediated endocytosis. As the endosome acidifies, the toxin undergoes a conformational change that allows its translocation domain to insert into the membrane, forming a pore. The N-terminal enzymatic domain is translocated to the cytosolic side, where the binding of host cytosolic inositol hexakisphosphate (IP6) triggers the toxin's built-in autoprotease activity. This cleavage releases the active glucosyltransferase domain into the cytosol. Finally, this active domain covalently attaches a glucose molecule to Rho family GTPases, irreversibly inactivating them. The loss of Rho GTPase function causes collapse of the actin cytoskeleton, leading to cell rounding, apoptosis, and the loss of the colonic epithelial barrier (pseudomembranous colitis).

Step-by-Step Solution

1
Identify the clinical syndrome and causative organism.
The patient has severe pseudomembranous colitis caused by Clostridioides difficile.
Recent antibiotic use, marked leukocytosis, and characteristic yellow-white colonic plaques are pathognomonic.
2
Identify the primary virulence factors.
C. difficile produces Toxin A (TcdA, an enterotoxin) and Toxin B (TcdB, a cytotoxin).
Both are large clostridial toxins that share a similar tripartite structure and intracellular mechanism of action.
3
Trace the initial cellular entry of the toxin.
The toxin binds to surface receptors and is internalized into early endosomes.
Extracellular large toxins must gain access to the intracellular cytosolic space to exert their enzymatic effects.
4
Determine how the active domain escapes the endosome into the cytosol.
Endosomal acidification drives membrane insertion, followed by host IP6-dependent autoproteolysis.
The low pH alters the toxin conformation to form a pore, and host cytosolic IP6 acts as a specific trigger to cleave and release the glucosyltransferase domain exactly where it is needed.
5
Identify the ultimate enzymatic target and physiological consequence.
The toxin glycosylates Rho GTPases, causing actin depolymerization.
Rho family proteins dynamically control the actin cytoskeleton; their targeted inactivation leads to cell rounding, barrier breakdown, and cell death, creating the mucosal pseudomembranes.

Key Concept

Clostridioides difficile Toxins A and B (large clostridial toxins) mediate their cellular destruction through a tightly regulated sequence: receptor binding, endocytosis, IP6-induced autoproteolysis, and the glycosylation of Rho GTPases, which ultimately disrupts the actin cytoskeleton.
Estimated Time:1m 30s
Question 3488Question →

An attending physician is conducting bedside rounds in the infectious disease unit and discussing a newly admitted patient with a history of intravenous drug use. The patient presents with a two-week history of fever, fatigue, and a new-onset cardiac murmur, raising high clinical suspicion for infective endocarditis. The physician asks the medical team to evaluate for classic peripheral stigmata of this disease during the physical examination. Which of the following physical examination findings are highly characteristic of this condition? (Select all that apply.)

Select all that apply

Show answer & explanation

Answer: Tender, violaceous nodules located on the pads of the fingers and toes; Painless, erythematous macules distributed on the palms and soles; Linear, dark red streaks appearing beneath the nail beds

Answer

The correct physical examination findings are tender nodules on the finger pads (Osler nodes), painless macules on the palms and soles (Janeway lesions), and linear red streaks under the nails (splinter hemorrhages).
The correct selections represent the classic peripheral stigmata of infective endocarditis. Osler nodes are tender, violaceous subcutaneous nodules typically found on the pads of the fingers and toes, caused by immune complex deposition. Janeway lesions are painless, erythematous macules located on the palms and soles, caused by septic microemboli. Splinter hemorrhages are dark red, linear streaks in the nail beds resulting from capillary damage and microembolization. The presence of these findings strongly supports the clinical diagnosis of infective endocarditis in a febrile patient with a new murmur.

Step-by-Step Solution

1
Identify the primary suspected diagnosis based on the clinical vignette.
The patient has a history of intravenous drug use, fever, and a new murmur, which strongly points to infective endocarditis.
Establishing the working diagnosis determines which specific physical exam signs to look for.
2
Recall the classic peripheral physical examination stigmata associated with infective endocarditis.
The classic findings include Osler nodes, Janeway lesions, splinter hemorrhages, and Roth spots.
These findings are key diagnostic clues resulting from microemboli and immune complex deposition in the systemic circulation.
3
Match the recalled clinical signs with the given answer choices.
Tender nodules on fingertips match Osler nodes; painless macules on palms/soles match Janeway lesions; linear subungual streaks match splinter hemorrhages.
Accurate recognition of the descriptive medical terminology for these signs allows for the selection of the correct options.

Key Concept

Physical stigmata of infective endocarditis
Question 3489Question →

During a critical care rotation, a medical team is analyzing how different pharmacological interventions alter the dose-response curves of endogenous neurotransmitters or exogenous full agonists. Match each clinical drug scenario to the most accurate description of its pharmacodynamic effect on the primary agonist's dose-response curve.

Click a left item, then click its matching right item

Items

Administration of naloxone to a patient receiving a continuous morphine infusion
Treatment with phenoxybenzamine in a patient with highly elevated endogenous norepinephrine
Initiation of buprenorphine in a patient currently dependent on high-dose oxycodone
Administration of midazolam in the presence of endogenous gamma-aminobutyric acid

Matches

Show answer & explanation

Answer

Naloxone matches with a rightward curve shift (competitive antagonism). Phenoxybenzamine matches with a downward curve shift (irreversible non-competitive antagonism). Buprenorphine matches with producing a submaximal response and lowering a full agonist's effect (partial agonism). Midazolam matches with a leftward curve shift (positive allosteric modulation).
Each pharmacological agent possesses a unique interaction at the receptor level. Naloxone (competitive antagonist) shifts the dose-response curve to the right by increasing the apparent ED50ED_{50}. Phenoxybenzamine (irreversible non-competitive antagonist) shifts the curve downward by decreasing EmaxE_{max}. Buprenorphine (partial agonist) plateaus at a submaximal effect and antagonizes full agonists. Midazolam (positive allosteric modulator) shifts the curve to the left by decreasing the apparent ED50ED_{50} of GABA.

Step-by-Step Solution

1
Determine the pharmacodynamic receptor mechanism for naloxone.
Naloxone is a reversible competitive antagonist at opioid receptors.
Competitive antagonists compete for the active site but can be overcome with higher agonist concentrations, increasing ED50ED_{50} without changing EmaxE_{max}.
2
Determine the pharmacodynamic receptor mechanism for phenoxybenzamine.
Phenoxybenzamine is an irreversible non-competitive antagonist at alpha receptors.
Irreversible binding permanently decreases the pool of available receptors, which lowers the overall EmaxE_{max} but leaves the ED50ED_{50} of functional receptors unchanged.
3
Determine the pharmacodynamic receptor mechanism for buprenorphine.
Buprenorphine is a partial agonist.
Partial agonists possess submaximal intrinsic activity. When combined with a full agonist, they displace the full agonist and lower the net receptor activation, acting as functional antagonists.
4
Determine the pharmacodynamic receptor mechanism for midazolam.
Midazolam is a positive allosteric modulator.
Positive allosteric modulators increase the receptor's affinity for the primary endogenous ligand (GABA), meaning less ligand is required to achieve the same effect (leftward shift, decreased ED50ED_{50}).

Key Concept

Pharmacodynamic receptor interactions and their specific effects on dose-response curve parameters (EmaxE_{max} and ED50ED_{50}).
Question 3490Question →

A 62-year-old woman is evaluated on the inpatient medical ward for sudden clinical deterioration. She was admitted 4 days ago for a complicated urinary tract infection presenting with fever, right-sided flank pain, and dysuria. Initial urine cultures grew lactose-fermenting, indole-negative Gram-negative rods. Susceptibility testing demonstrated that the isolate was susceptible to ceftriaxone, cefepime, ciprofloxacin, and meropenem. She was started on intravenous ceftriaxone and initially showed clinical improvement, becoming afebrile by day 2. Today, she has developed recurrent chills and flank pain. Her temperature is 39.0∘C39.0^\circ\text{C} (102.2∘F102.2^\circ\text{F}), blood pressure is 90/55 mmHg90/55\text{ mmHg}, and pulse is 112/min112/\text{min}. Repeat blood and urine cultures are drawn and subsequently grow the same organism. Susceptibility testing of the new isolate reveals resistance to ceftriaxone, but retained susceptibility to cefepime, ciprofloxacin, and meropenem. Which of the following molecular mechanisms most likely explains this pathogen's acquired resistance to the current antimicrobial therapy?

Show answer & explanation

Answer: Selection of a mutant strain with stably derepressed chromosomal beta-lactamase production

Answer

Selection of a mutant strain with stably derepressed chromosomal beta-lactamase production
The patient is infected with a likely Enterobacter species (lactose-fermenting, indole-negative), which is a member of the SPICE/SPACE group of organisms (Serratia, Pseudomonas/Providencia, Acinetobacter/Morganella, Citrobacter, Enterobacter). These organisms characteristically possess an inducible, chromosomal ampC gene. When initially tested, the wild-type population produces low levels of the AmpC enzyme and appears susceptible to third-generation cephalosporins. However, treatment with a beta-lactam antibiotic such as ceftriaxone exerts a strong selective pressure. While the majority of the bacteria are eradicated, a small preexisting subpopulation with a mutation in the AmpC regulatory genes (typically ampD) survives. These mutants are 'stably derepressed,' meaning they continuously hyperproduce AmpC beta-lactamase regardless of inducer presence. This enzyme efficiently hydrolyzes ceftriaxone, leading to treatment failure. Importantly, AmpC beta-lactamases have low affinity for fourth-generation cephalosporins (cefepime) and carbapenems, which explains why the isolate remains susceptible to these agents.

Step-by-Step Solution

1
Identify the likely pathogen based on microbiologic characteristics.
The organism is a lactose-fermenting, indole-negative Gram-negative rod, highly suggestive of Enterobacter cloacae or a closely related species (SPICE/SPACE organisms).
Recognizing the organism class is essential to anticipating its intrinsic resistance mechanisms.
2
Analyze the change in the susceptibility profile during treatment.
The pathogen initially appeared susceptible to ceftriaxone, but rapidly developed resistance to it while remaining susceptible to cefepime (a fourth-generation cephalosporin) and meropenem.
This specific pattern of resistance emerging during therapy with a third-generation cephalosporin is a classic hallmark of a specific molecular mechanism.
3
Determine the molecular mechanism underlying this susceptibility pattern.
Organisms with an inducible chromosomal ampC gene can undergo selection during beta-lactam therapy. The antibiotic kills the susceptible wild-type population, leaving behind a spontaneously mutated subpopulation that is 'stably derepressed' (hyperproducing AmpC beta-lactamase).
AmpC beta-lactamases readily hydrolyze first-, second-, and third-generation cephalosporins (like ceftriaxone) but have very low affinity for fourth-generation cephalosporins (like cefepime) and carbapenems.

Key Concept

Organisms with inducible chromosomal AmpC beta-lactamases (e.g., Enterobacter, Serratia, Citrobacter) can develop rapid clinical resistance to third-generation cephalosporins via the selection of stably derepressed mutant subpopulations that hyperproduce the enzyme. Cefepime and carbapenems typically remain effective.
Question 3491Question →

A 68-year-old man with a history of poorly controlled type 2 diabetes and hypertension is brought to the emergency department due to the sudden onset of severe, continuous room-spinning dizziness, intractable nausea, and difficulty walking that started 3 hours ago. He denies hearing loss, tinnitus, or headache. Blood pressure is 168/94 mmHg. On bedside evaluation, he exhibits spontaneous horizontal nystagmus that beats to the right on rightward gaze and to the left on leftward gaze. When the physician asks the patient to fixate on the physician's nose and rapidly rotates the patient's head to the right and left, the patient's eyes remain locked on the target without any refixation saccades. When an opaque card is alternately placed over each eye, there is a visible vertical refixation movement of the uncovered eye. Which of the following statements provides the most accurate interpretation of this patient's physical examination findings?

Show answer & explanation

Answer: The absence of corrective refixation saccades during rapid head rotation indicates an intact vestibulo-ocular reflex, localizing the pathology to the central nervous system.

Answer

The physical examination findings indicate an intact vestibulo-ocular reflex (normal head impulse test), direction-changing nystagmus, and skew deviation. In a patient with continuous acute vertigo, an intact vestibulo-ocular reflex strongly localizes the pathology to the central nervous system, meaning the correct statement identifies that the absence of corrective saccades points to a central lesion.
The patient's clinical presentation is consistent with acute vestibular syndrome. The HINTS exam (Head Impulse, Nystagmus, Test of Skew) is utilized to differentiate central (e.g., cerebellar or brainstem stroke) from peripheral (e.g., vestibular neuritis) etiologies. A normal head impulse test (absence of corrective saccades) indicates an intact vestibulo-ocular reflex, meaning the peripheral vestibular apparatus is functioning normally. Paradoxically, this localizes the lesion to the central nervous system. The additional presence of direction-changing nystagmus and skew deviation (vertical refixation on alternate cover testing) further strongly confirms a central etiology.

Step-by-Step Solution

1
Identify the patient's clinical syndrome based on the history.
The patient has an acute onset of continuous vertigo, nausea, and truncal ataxia, defining acute vestibular syndrome (AVS).
Establishing the clinical syndrome is necessary to determine the appropriate diagnostic framework and physical examination maneuvers.
2
Analyze the nystagmus finding.
The patient exhibits direction-changing nystagmus (beats right on rightward gaze, left on leftward gaze).
Direction-changing nystagmus is a highly specific sign of a central nervous system lesion, whereas peripheral nystagmus is unidirectional.
3
Interpret the head impulse test.
The absence of corrective saccades indicates a normal, intact vestibulo-ocular reflex.
In the context of AVS, an intact vestibulo-ocular reflex strongly suggests the vertigo is originating from a central mismatch rather than a broken peripheral vestibular nerve.
4
Evaluate the alternate cover test result.
The presence of vertical refixation indicates a skew deviation.
Skew deviation points to a brainstem lesion disrupting otolithic pathways, further confirming a central etiology.
5
Synthesize the physical examination findings.
All three components of the HINTS exam (normal head impulse, direction-changing nystagmus, skew deviation) point to a central stroke.
Understanding how these physical signs localize the pathology is essential for preventing premature closure on a benign peripheral diagnosis.

Key Concept

The HINTS exam (Head Impulse, Nystagmus, Test of Skew) is a critical bedside physical examination tool used to differentiate central from peripheral causes of acute vestibular syndrome.
Question 3492Question →

An infectious disease specialist is evaluating a male patient with multidrug-resistant bacteremia to design an appropriate antimicrobial dosing regimen.

Patient details:
- Age: 6868 years
- Weight: 72 kg72 \text{ kg}
- Serum creatinine: 2.0 mg/dL2.0 \text{ mg/dL} (stable over the past week)

The team plans to start a novel continuous intravenous antibiotic. Pharmacokinetic data indicates that this drug is excreted exclusively by glomerular filtration, and its clearance is directly equal to the patient's creatinine clearance. The target steady-state plasma concentration (CssC_{ss}) required for bactericidal efficacy is 15 mg/L15 \text{ mg/L}.

Assuming the Cockcroft-Gault equation is CrCl=(140−Age)×Weight in kg72×Serum Creatinine in mg/dL×(0.85 if female)\text{CrCl} = \frac{(140 - \text{Age}) \times \text{Weight in kg}}{72 \times \text{Serum Creatinine in mg/dL}} \times (0.85 \text{ if female}), what continuous intravenous infusion rate (in mg/hr\text{mg/hr}) is required to achieve the target steady-state concentration?

Show answer & explanation

Answer: 32.4

Answer

32.4
The maintenance infusion rate required to maintain a steady-state plasma concentration is determined by the fundamental pharmacokinetic relationship: Infusion Rate=Clearance×Css\text{Infusion Rate} = \text{Clearance} \times C_{ss}. The patient's creatinine clearance, calculated via the Cockcroft-Gault equation, is (140−68)×7272×2.0=36 mL/min\frac{(140 - 68) \times 72}{72 \times 2.0} = 36 \text{ mL/min}. Converting this to liters per hour yields 2.16 L/hr2.16 \text{ L/hr} (36 mL/min×60 min/hr÷1000 mL/L36 \text{ mL/min} \times 60 \text{ min/hr} \div 1000 \text{ mL/L}). Multiplying this clearance by the target steady-state concentration of 15 mg/L15 \text{ mg/L} results in the required infusion rate of 32.4 mg/hr32.4 \text{ mg/hr}.

Step-by-Step Solution

1
Calculate the patient's creatinine clearance (CrCl).
36 mL/min36 \text{ mL/min}
The drug's clearance is directly equal to CrCl, which must be estimated using the Cockcroft-Gault equation before dosing can be determined.
2
Convert clearance units from mL/min\text{mL/min} to L/hr\text{L/hr}.
2.16 L/hr2.16 \text{ L/hr}
The target infusion rate is requested in mg/hr\text{mg/hr} and concentration is given in mg/L\text{mg/L}. Matching the volume and time units is required for accurate calculation.
3
Calculate the maintenance infusion rate.
32.4 mg/hr32.4 \text{ mg/hr}
At steady state, the rate of drug administration (infusion rate) must equal the rate of elimination, represented by the equation: Infusion Rate=Clearance×Css\text{Infusion Rate} = \text{Clearance} \times C_{ss}.

Key Concept

The maintenance infusion rate required to achieve a target steady-state concentration is the product of the drug's clearance and the desired concentration. Renal clearance can be estimated using the Cockcroft-Gault equation.
Question 3493Question →

A 7272-year-old man is brought to the emergency department by his family due to a rapidly expanding, painful swelling in his right thigh over the past 2424 hours. He denies any significant trauma, reporting only a minor bump against a doorway. His medical history is significant for rheumatoid arthritis and hypertension. Current medications include methotrexate, amlodipine, and occasionally ibuprofen.

Vital signs show a temperature of 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F), heart rate of 118118/min, blood pressure of 98/6298/62 mmHg, and respiratory rate of 2020/min. Physical examination reveals a massive, tense, ecchymotic hematoma encompassing the right posterior thigh.

Laboratory studies are obtained:

TestResultReference Range
Hemoglobin7.27.2 g/dL13.5−17.513.5-17.5 g/dL
Platelet count285,000/μL285,000/\mu L150,000−400,000/μL150,000-400,000/\mu L
Prothrombin time (PT)12.312.3 s11−1411-14 s
Activated partial thromboplastin time (aPTT)9494 s25−4025-40 s
Fibrinogen360360 mg/dL150−400150-400 mg/dL

A mixing study is performed using a 1:11:1 ratio of the patient's plasma and normal pooled plasma. The aPTT immediately corrects to 3232 s. However, after incubation at 37∘C37^\circ C for 22 hours, the aPTT prolongs to 8282 s.

The patient remains tachycardic, and the hematoma appears to be enlarging. Which of the following best describes the mechanism of action of the most appropriate immediate pharmacotherapy for this patient?

Show answer & explanation

Answer: Directly activates factor X on the surface of activated platelets independent of the intrinsic tenase complex

Answer

The correct answer is the pharmacotherapy that directly activates factor X on the surface of activated platelets independent of the intrinsic tenase complex.
The patient's presentation of spontaneous severe hemorrhage, isolated prolonged aPTT, and a mixing study that corrects immediately but prolongs after incubation is pathognomonic for acquired hemophilia A (factor VIII autoantibodies). The immediate priority for life-threatening bleeding in these patients is hemostatic control with a bypassing agent, such as recombinant activated factor VII (rFVIIa) or activated prothrombin complex concentrate (aPCC). Recombinant FVIIa works by directly binding to the surface of activated platelets at the site of injury and activating factor X to factor Xa, thereby completely bypassing the need for the factor VIIIa/IXa (intrinsic tenase) complex to generate a thrombin burst.

Step-by-Step Solution

1
Assess the patient's clinical stability and primary presentation.
The patient has a life-threatening spontaneous hemorrhage (massive thigh hematoma, severe hemoglobin drop) with hemodynamic compromise (tachycardia, hypotension).
Recognizing a hemorrhagic emergency dictates the need for immediate hemostatic control rather than long-term definitive therapy.
2
Interpret the initial coagulation panel.
The patient has an isolated, markedly prolonged aPTT with a normal PT and platelet count.
An isolated aPTT prolongation points to an intrinsic pathway defect (factors XII, XI, IX, or VIII) rather than a common pathway or platelet issue.
3
Analyze the results of the immediate and incubated mixing studies.
Immediate correction suggests a factor deficiency, but subsequent prolongation after 2-hour incubation is the pathognomonic hallmark of a time- and temperature-dependent inhibitor.
This specific pattern confirms the diagnosis of Acquired Hemophilia A (autoantibodies against factor VIII), which is highly associated with autoimmune conditions like rheumatoid arthritis.
4
Determine the optimal pharmacologic intervention for acute bleeding in this specific condition.
The primary treatment requires bypassing agents (such as recombinant activated factor VII or activated prothrombin complex concentrate) rather than standard factor VIII replacement.
Because the circulating autoantibodies are active and high-titer, giving standard factor VIII or stimulating its release will fail, as the new factor will simply be neutralized.
5
Identify the molecular mechanism of the selected bypassing agent.
Recombinant activated factor VII (rFVIIa) works by directly activating factor X on activated platelets, completely bypassing the inhibited factor VIII in the intrinsic tenase complex.
The question specifically asks for the mechanism of action of the most appropriate immediate therapy.

Key Concept

Diagnosis of Acquired Hemophilia A via incubated mixing study and acute management using bypassing agents.

Alternative Method

While recombinant activated factor VII (rFVIIa) is heavily favored in this description, activated prothrombin complex concentrate (aPCC, also known as FEIBA) is an equally valid alternative bypassing agent for acute bleeding in acquired hemophilia A. Its mechanism involves providing pre-activated factor IXa and factor Xa to bypass the inhibitor.
Estimated Time:2m 0s
Question 3494Question →

Evaluate the following four patient scenarios presenting with hematologic and coagulation abnormalities. For each clinical presentation, select the most accurate underlying pathophysiologic mechanism driving the disease process.

Click a left item, then click its matching right item

Items

A 28-year-old primigravida at 34 weeks gestation with right upper quadrant pain, elevated transaminases, schistocytes, and a platelet count of 65,000/mcL with normal PT and aPTT.
A 32-year-old woman with systemic lupus erythematosus exhibiting new-onset confusion, fever, schistocytes, and a platelet count of 18,000/mcL with normal PT and aPTT.
A 45-year-old man undergoing induction chemotherapy for acute promyelocytic leukemia with diffuse mucosal oozing, hypofibrinogenemia, elevated D-dimer, and prolonged PT and aPTT.
A 6-year-old child with pale skin, oliguria, and petechiae following a bout of bloody diarrhea, presenting with schistocytes and a platelet count of 45,000/mcL with normal PT and aPTT.

Matches

Show answer & explanation

Answer

HELLP syndrome is paired with abnormal placentation; TTP is paired with ADAMTS13 inhibition; DIC is paired with systemic coagulation activation; and HUS is paired with exotoxin-mediated damage.
The correct matches effectively differentiate the primary microangiopathic hemolytic anemias (MAHA) and consumptive coagulopathies. HELLP syndrome is specific to pregnancy and driven by abnormal placentation resulting in hepatic sinusoid fibrin deposition. TTP is caused by ADAMTS13 deficiency, often due to autoantibodies in patients with autoimmune diseases like SLE, which prevents the cleavage of large von Willebrand factor multimers. DIC involves the widespread activation of the coagulation cascade, depleting both platelets and clotting factors (resulting in prolonged PT/aPTT), often triggered by the release of procoagulants in states like acute promyelocytic leukemia. HUS is characterized by Shiga exotoxin-mediated endothelial injury, predominantly affecting the kidneys after a diarrheal illness.

Step-by-Step Solution

1
Analyze the coagulation profile for each patient to differentiate between disorders of primary hemostasis or isolated microangiopathy and secondary hemostatic consumptive disorders.
Patients 1, 2, and 4 have normal PT/aPTT, indicating primary hemostatic or localized microangiopathic processes. Patient 3 has prolonged PT/aPTT, indicating a widespread consumptive coagulopathy.
Normal PT and aPTT effectively rule out DIC and point towards TTP, HUS, or HELLP syndrome, as these primarily consume platelets rather than systemic clotting factors.
2
Identify the distinct clinical triggers and presentations for the patients with normal PT/aPTT.
Patient 1 is in the third trimester of pregnancy with liver involvement (HELLP). Patient 2 has SLE and prominent neurologic symptoms (TTP). Patient 4 is a child presenting with post-diarrheal renal failure (HUS).
Because the laboratory features of microangiopathic hemolytic anemias overlap heavily, the clinical context is essential to separate them.
3
Match the identified conditions with their specific underlying pathophysiologic mechanisms.
HELLP matches abnormal placentation. TTP matches ADAMTS13 inhibition. DIC matches systemic coagulation activation. HUS matches Shiga exotoxin damage.
Linking the clinical syndrome directly to its molecular and hemodynamic driver solidifies the final answer.

Key Concept

Differentiation of microangiopathic hemolytic anemias and consumptive coagulopathies based on clinical context and coagulation cascade parameters.
Question 3495Question →

A 54-year-old man with a history of severe alcohol use disorder is brought to the emergency department due to the sudden onset of excruciating, band-like epigastric pain radiating to his back. He reports multiple episodes of nonbilious vomiting over the past 12 hours. On arrival, his temperature is 38.4°C (101.1°F), blood pressure is 92/58 mmHg, and heart rate is 122/min. Physical examination reveals scleral icterus and significant epigastric tenderness with involuntary guarding. Ecchymoses are noted around the umbilicus. Laboratory studies are as follows:

White blood cell count: 19,500/mm³
Total bilirubin: 3.2 mg/dL
Aspartate aminotransferase (AST): 310 U/L
Alanine aminotransferase (ALT): 145 U/L
Alkaline phosphatase: 210 U/L
Lipase: 4,800 U/L (normal: 10-140 U/L)
Total calcium: 6.8 mg/dL (normal: 8.4-10.2 mg/dL)
Albumin: 3.4 g/dL (normal: 3.5-5.0 g/dL)
Prothrombin time: 15 seconds (normal: 11-13 seconds)

An abdominal CT scan demonstrates diffuse pancreatic enlargement with indistinct margins and extensive peripancreatic fluid collections. Which of the following pathophysiological mechanisms is the primary cause of this patient's hypocalcemia?

Show answer & explanation

Answer: Enzymatic degradation of triglycerides by released lipases and subsequent precipitation of free fatty acids with calcium

Answer

Enzymatic degradation of triglycerides by released lipases and subsequent precipitation of free fatty acids with calcium
The correct answer accurately describes enzymatic fat necrosis, a hallmark of acute pancreatitis. Pancreatic lipases released from damaged acinar cells degrade triglycerides in peripancreatic adipose tissue into free fatty acids. These negatively charged free fatty acids bind to positively charged calcium ions in the serum, forming insoluble calcium soaps in a process known as saponification. This massive sequestration of calcium in the retroperitoneum leads to true, profound systemic hypocalcemia, which is a marker of severe disease and poor prognosis.

Step-by-Step Solution

1
Diagnose the patient's primary condition based on the clinical presentation and laboratory findings.
The patient has severe acute pancreatitis, evidenced by severe epigastric pain, highly elevated lipase, and periumbilical ecchymosis (Cullen sign).
Establishing the primary diagnosis is necessary to understand the subsequent systemic complications.
2
Identify the specific type of cellular injury associated with acute pancreatitis.
Acute pancreatitis is characterized by enzymatic fat necrosis of the peripancreatic adipose tissue.
Pancreatic acinar cell injury releases active lipases and proteases into the surrounding tissue.
3
Determine the biochemical consequence of enzymatic fat necrosis.
Lipases cleave triglycerides into free fatty acids, which then undergo saponification by binding to circulating calcium ions.
This precipitation of calcium into insoluble soaps physically removes calcium from the serum, explaining the profound true hypocalcemia (6.8 mg/dL) seen in this patient.

Key Concept

Saponification in Enzymatic Fat Necrosis
Estimated Time:1m 30s
Question 3496Question →

A 29-year-old female medical resident presents to the employee health clinic with a 3-week history of unintentional weight loss, palpitations, and generalized anxiety. Physical examination reveals a resting heart rate of 110/min, a fine tremor in her outstretched hands, and a normal-sized, non-tender thyroid gland. Laboratory studies demonstrate a markedly suppressed thyroid-stimulating hormone (TSH) level and an elevated free thyroxine (T4) level. A subsequent radioactive iodine uptake scan reveals near-zero uptake. Which of the following historical inquiries is most essential to establishing the etiology of this patient's condition?

Show answer & explanation

Answer: Current use of unprescribed or over-the-counter thyroid hormone preparations

Answer

The correct answer is inquiring about the current use of unprescribed or over-the-counter thyroid hormone preparations.
The patient's presentation of thyrotoxicosis with a normal-sized, non-tender thyroid gland and near-zero radioactive iodine uptake is highly suspicious for exogenous thyroid hormone ingestion (factitious thyrotoxicosis). The fact that she is a medical resident provides a classic epidemiological clue for this condition. Therefore, directly inquiring about her use of unprescribed thyroid hormone preparations is the most critical element of the medical history to establish the diagnosis.

Step-by-Step Solution

1
Identify the clinical syndrome from the patient's symptoms and initial labs.
The patient has overt thyrotoxicosis (weight loss, palpitations, tremor, suppressed TSH, elevated free T4).
Establishing the biochemical state is the first step in diagnosing thyroid dysfunction.
2
Interpret the radioactive iodine uptake (RAIU) scan results.
Near-zero uptake indicates the thyroid gland is not actively synthesizing hormone.
This critically rules out causes of endogenous overproduction, such as Graves disease and toxic nodular goiter.
3
Differentiate among causes of low-uptake thyrotoxicosis.
The primary differential includes thyroiditis (typically painful or postpartum) and exogenous thyroid hormone ingestion.
Narrowing the differential diagnosis focuses the necessary historical evaluation.
4
Synthesize physical exam findings and demographic clues.
A non-tender, normal-sized thyroid in a healthcare professional with low RAIU strongly suggests factitious thyrotoxicosis.
Medical professionals have increased access to and knowledge of thyroid hormone, making surreptitious use a classic board presentation.
5
Determine the most critical historical inquiry to confirm the diagnosis.
Asking specifically about the use of unprescribed or over-the-counter thyroid hormone is essential.
The diagnosis of factitious thyrotoxicosis relies heavily on obtaining this specific medication history.

Key Concept

Factitious thyrotoxicosis presents with clinical hyperthyroidism, suppressed TSH, elevated thyroid hormones, a non-tender thyroid gland, and near-zero radioactive iodine uptake. Establishing the diagnosis requires targeted medical history evaluation regarding exogenous hormone use.
Question 3497Question →

Match each patient's clinical presentation to the specific molecular mechanism of the responsible pathogen's primary virulence factor.

Click a left item, then click its matching right item

Items

A 5-year-old boy with oliguria, severe thrombocytopenia, and schistocytes on a peripheral smear following an episode of hemorrhagic colitis.
A 2-month-old unvaccinated infant presenting with severe paroxysmal coughing spells, post-tussive emesis, and a marked absolute lymphocytosis.
A 28-year-old trauma patient who develops rapidly progressive myonecrosis, hemorrhagic bullae, and tissue gas formation following a compound fracture.
A 50-year-old livestock worker presenting with severe dyspnea, shock, and a significantly widened mediastinum on chest radiography.

Matches

Show answer & explanation

Answer

The boy with HUS matches the 28S rRNA cleavage mechanism. The infant with pertussis matches the ADP-ribosylation of the Gi alpha subunit. The trauma patient with gas gangrene matches the degradation of phosphatidylcholine. The livestock worker with inhalation anthrax matches the direct synthesis of cyclic AMP.
Each clinical presentation classically aligns with a specific bacterial pathogen and its corresponding exotoxin mechanism. Hemolytic Uremic Syndrome (HUS) following bloody diarrhea is caused by EHEC's Shiga-like toxin, which halts eukaryotic protein synthesis by cleaving an adenine residue from the 28S rRNA of the 60S ribosomal subunit. The infant with a paroxysmal cough and extreme lymphocytosis has a Bordetella pertussis infection; pertussis toxin functions by ADP-ribosylating the inhibitory G-protein (Gi), rendering it inactive and thus preventing the normal suppression of host adenylate cyclase. The trauma patient with rapidly progressive gas gangrene is infected with Clostridium perfringens; its primary virulence factor is alpha toxin (a lecithinase/phospholipase C), which destroys cell membranes by enzymatically degrading phosphatidylcholine and sphingomyelin. The livestock worker with a widened mediastinum has inhalation anthrax caused by Bacillus anthracis; its Edema Factor is a calmodulin-dependent adenylate cyclase that directly enters host cells and synthesizes cyclic AMP, leading to severe edema and fluid accumulation.

Step-by-Step Solution

1
Analyze each clinical vignette to identify the causative organism.
The vignettes describe Enterohemorrhagic E. coli (EHEC), Bordetella pertussis, Clostridium perfringens, and Bacillus anthracis, respectively.
Accurate pathogen identification is required to determine the specific virulence factors involved.
2
Identify the primary exotoxin responsible for the classical manifestations in each infection.
EHEC: Shiga-like toxin. B. pertussis: Pertussis toxin. C. perfringens: Alpha toxin. B. anthracis: Edema factor (along with lethal factor).
The toxins mediate the severe systemic or local effects described in the scenarios.
3
Map the identified toxin to its precise molecular or cellular mechanism.
Shiga-like toxin cleaves 28S rRNA. Pertussis toxin ADP-ribosylates Gi. Alpha toxin degrades phospholipids. Edema factor directly synthesizes cAMP.
This establishes the final correct matches for the foundational science mechanisms.

Key Concept

The precise cellular mechanisms of major bacterial exotoxins and their correlation with distinct clinical syndromes.
Question 3498Question →

During a comprehensive medical history evaluation, clinicians must actively query patients regarding the use of over-the-counter botanical and herbal supplements, as patients frequently omit these from routine medication reconciliation. Match each patient's clinical presentation and intended supplement use with the responsible botanical agent and its underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 50-year-old female renal transplant recipient on tacrolimus presents with an acute rise in serum creatinine; biopsy confirms acute cellular rejection. She recently started an over-the-counter botanical supplement for mild depressive symptoms.
A 65-year-old man presents with treatment-resistant hypertension, severe hypokalemia, and metabolic alkalosis. He denies diuretic use but admits to daily consumption of a natural root extract to soothe chronic dyspepsia.
A 42-year-old woman presents with progressive chronic kidney disease and gross hematuria; cystoscopy reveals a multifocal upper tract urothelial carcinoma. She reports past prolonged use of a traditional botanical preparation for weight loss.
A 35-year-old man develops rapid-onset painful hepatomegaly and ascites. Imaging shows patent main hepatic veins, but liver biopsy reveals sinusoidal obstruction syndrome (veno-occlusive disease). He regularly consumes a home-brewed tea made from a plant used for joint healing.
A 28-year-old woman with no prior medical history presents with acute jaundice, encephalopathy, and fulminant hepatic failure. She reports drinking large quantities of a traditional South Pacific botanical beverage to manage severe anxiety.

Matches

Show answer & explanation

Answer

Successfully matching each clinical presentation requires integrating the patient's reported reason for herbal use (e.g., depression, dyspepsia, weight loss) with the specific toxidrome (e.g., rejection, pseudohyperaldosteronism, nephropathy).
Each correct match relies on synthesizing the patient's chief complaint, intended use of the botanical supplement, and the specific resulting toxidrome. Accurate medical history evaluation requires active inquiry into herbal products, as they possess potent pharmacologic properties.

Step-by-Step Solution

1
Evaluate the transplant patient with acute rejection using a supplement for depression.
Identify St. John's wort as the CYP3A4 inducer.
Patients often self-treat mood symptoms without realizing herbal remedies can induce drug metabolism and severely lower tacrolimus levels.
2
Analyze the hypertensive, hypokalemic patient using a root extract for dyspepsia.
Identify licorice root (glycyrrhizin) causing apparent mineralocorticoid excess.
Glycyrrhizin inhibits the enzyme that normally deactivates cortisol in the kidney, allowing cortisol to aberrantly stimulate mineralocorticoid receptors.
3
Assess the patient with nephropathy, urothelial cancer, and a history of weight-loss supplements.
Identify aristolochic acid exposure.
Aristolochic acid is uniquely nephrotoxic and highly carcinogenic to the urothelium.
4
Evaluate the patient with sinusoidal obstruction syndrome drinking joint-healing tea.
Identify pyrrolizidine alkaloid toxicity (e.g., comfrey).
These alkaloids specifically injure hepatic sinusoidal endothelial cells, leading to non-thrombotic occlusion.
5
Assess the young patient with fulminant liver failure taking an anxiolytic beverage.
Identify kava kava hepatotoxicity.
Kava is known to cause severe, sometimes fatal, acute liver injury.

Key Concept

Eliciting a detailed history of herbal and dietary supplement use is essential for diagnosing occult toxidromes, drug-supplement interactions, and specific end-organ toxicities that perfectly mimic classic medical conditions.
Question 3499Question →

A 61-year-old woman presents to the outpatient internal medicine clinic for the evaluation of progressive fatigue, lower extremity edema, and exertional dyspnea that have worsened over the last four months. During the clinical interview, the physician observes a sudden onset of violaceous flushing over her face and upper chest that resolves spontaneously after 10 minutes. The patient mentions a one-year history of episodic, explosive watery diarrhea and intermittent wheezing. On physical examination, her lungs are clear to auscultation bilaterally. Abdominal examination reveals a tender, enlarged liver with a distinct systolic pulsation. Which of the following physical examination findings are characteristically present in this patient's underlying cardiovascular condition? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: A holosystolic murmur at the left lower sternal border that augments in intensity during inspiration; A prominent systolic wave in the jugular venous pulse that obscures the x descent

Answer

The correct findings are a holosystolic murmur at the left lower sternal border that augments during inspiration and a prominent systolic wave in the jugular venous pulse that obscures the x descent.
The correct answers describe the classic physical examination findings of tricuspid regurgitation: a holosystolic murmur at the left lower sternal border that increases with inspiration (Carvallo sign) and a prominent 'c-v' (regurgitant) wave in the jugular venous pulse. This patient's classic triad of flushing, diarrhea, and wheezing, combined with right heart failure and a pulsatile liver, points to carcinoid syndrome with carcinoid heart disease. This condition causes plaque-like fibrotic deposits on the endocardium of the right heart, leading to tricuspid valve retraction and regurgitation.

Step-by-Step Solution

1
Analyze the patient's systemic symptoms to formulate an underlying diagnosis.
The combination of episodic flushing, watery diarrhea, and wheezing is highly characteristic of carcinoid syndrome.
These symptoms are caused by the systemic release of vasoactive substances like serotonin, histamine, and tachykinins from a neuroendocrine tumor (typically metastatic to the liver).
2
Correlate the systemic disease with the cardiovascular presentation.
The patient has signs of right-sided heart failure (edema, hepatomegaly) and a pulsatile liver, indicating carcinoid heart disease resulting in tricuspid regurgitation.
Carcinoid plaques form predominantly on the right-sided heart valves, leading to tricuspid regurgitation and/or pulmonic stenosis. The pulsatile liver is a hallmark of severe tricuspid regurgitation.
3
Identify the specific physical examination findings associated with tricuspid regurgitation.
Tricuspid regurgitation produces a holosystolic murmur that increases with inspiration (Carvallo sign) and a prominent systolic (c-v) wave in the jugular venous pulse.
Inspiration increases venous return to the right heart, amplifying right-sided murmurs. The incompetent tricuspid valve allows systolic backflow into the vena cava, producing the abnormal jugular venous pulse wave.

Key Concept

Carcinoid heart disease predominantly causes right-sided valvular lesions (tricuspid regurgitation and pulmonic stenosis) because vasoactive amines are inactivated in the lungs, typically sparing the left heart.
Question 3500Question →

A 6262-year-old man presents to the clinic for a routine follow-up. He has a history of end-stage renal disease (ESRD) requiring hemodialysis three times a week, as well as diet-controlled type 22 diabetes mellitus. Two weeks ago, the patient was hospitalized for a generalized tonic-clonic seizure, which was successfully treated. He was discharged on a maintenance regimen of oral phenytoin 300300 mg daily. Since discharge, he has had no further seizure activity and reports no side effects such as dizziness or unsteadiness.

Vital signs are within normal limits. Neurological examination reveals no nystagmus, normal tandem gait, and an intact Mini-Mental State Examination.

Recent laboratory studies reveal the following:

TestResultReference Range
Blood urea nitrogen7272 mg/dL77 - 2020 mg/dL
Serum creatinine6.86.8 mg/dL0.60.6 - 1.21.2 mg/dL
Serum albumin2.52.5 g/dL3.53.5 - 5.05.0 g/dL
Total serum phenytoin4.54.5 μ\mug/mL1010 - 2020 μ\mug/mL

Based on these findings, which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Continue the current phenytoin dosage and monitor the patient clinically

Answer

Continue the current phenytoin dosage and monitor the patient clinically.
The correct management is to continue the current dosage and monitor the patient clinically. Phenytoin is a highly lipophilic antiepileptic drug that is extensively bound to plasma albumin (approximately 90%90\% in healthy individuals). In patients with end-stage renal disease and hypoalbuminemia, the protein binding of phenytoin is significantly reduced. This occurs due to a combination of decreased available albumin molecules and competition for remaining binding sites by accumulated uremic toxins. Consequently, the fraction of unbound (free) phenytoin—which is the pharmacologically active form capable of crossing the blood-brain barrier—drastically increases. Because standard laboratory assays measure total (bound plus free) serum phenytoin, the reported total concentration will appear artificially low (4.54.5 μ\mu g/mL) even when the free drug concentration is highly therapeutic. The patient's actual adjusted total phenytoin level can be estimated using the Sheiner-Tozer formula for ESRD, which reveals that his active drug exposure is equivalent to a normal patient with a therapeutic total level. Given that the patient is clinically stable, seizure-free, and exhibiting no signs of toxicity, the current regimen is effective and should be maintained.

Step-by-Step Solution

1
Evaluate the patient's clinical status alongside the isolated laboratory abnormality.
The patient is seizure-free and asymptomatic without signs of toxicity, yet has a seemingly subtherapeutic total phenytoin level of 4.54.5 μ\mu g/mL.
Clinical context must always dictate the interpretation of therapeutic drug monitoring, especially in the presence of severe comorbidities.
2
Analyze the pharmacokinetic properties of the prescribed drug in relation to the patient's comorbidities.
Phenytoin is highly bound to serum albumin. The patient has ESRD (causing uremia) and significant hypoalbuminemia (2.52.5 g/dL).
Uremic toxins compete for albumin binding sites, and a low absolute albumin level provides fewer binding sites overall, significantly disrupting normal pharmacokinetics.
3
Determine the downstream effect of decreased protein binding on the drug's activity.
The unbound (free) fraction of phenytoin increases. Because standard assays measure total (bound + free) drug, the reported total concentration appears artificially low, even though the free (active) concentration is therapeutic.
Only the unbound drug can cross the blood-brain barrier to exert antiepileptic effects and dictate toxicity.
4
Select the most appropriate management based on combined clinical and pharmacokinetic data.
Because the patient is clinically stable and the free drug level is presumably in the target range, no dose adjustment is required.
Increasing the dose to normalize the total level would cause severe neurotoxicity.

Key Concept

Pharmacokinetic alterations of highly protein-bound drugs in end-stage renal disease and hypoalbuminemia.
PreviousPage 175 / 237Next
All practice questions — USMLE Step 3 | Examkin